Axsome Therapeutics Inc (AXSM) — Defensive Interval Ratio
Axsome Therapeutics Inc (AXSM) has a Defensive Interval Ratio of 209 days as of March 2026. Defensive assets of $251.06 Million (cash $-, short-term investments $-, receivables $251.06 Million) cover 209 days of daily cash needs of $1.20 Million/day. See working capital to net assets of Axsome Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Axsome Therapeutics Inc Defensive Interval Ratio (2016–2025)
This chart shows how Axsome Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 209 days, meaning defensive assets of $251.06 Million can fund 209 days of operations without new revenue. See Axsome Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Axsome Therapeutics Inc (2016–2025)
The table below presents the year-by-year Defensive Interval Ratio for Axsome Therapeutics Inc from 2016 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AXSM market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 216 days | $224.46 Million | $1.04 Million/day | $- | $- | ▼ -9 days |
| 2024 | 225 days | $142.00 Million | $630.42K/day | $- | $- | ▼ -24 days |
| 2023 | 249 days | $94.82 Million | $380.42K/day | $- | $- | ▲ +107 days |
| 2022 | 143 days | $37.70 Million | $264.55K/day | $- | $- | ▲ +143 days |
| 2021 | 0 days | $0.00 | $63.19K/day | $- | $- | ▲ +0 days |
| 2017 | 0 days | $0.00 | $33.36K/day | $- | $0.00 | ▲ +0 days |
| 2016 | 0 days | $0.00 | $19.65K/day | $- | $0.00 | — |